PATENT CLAIM ANALYSIS

Application Number: 15970776
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "001000"]

Abstract:
Provided herein are methods of treating glaucoma in a patient, comprising: obtaining a biological sample from the patient; testing the biological sample for presence of a mutation in Kir6.2 protein or KCNJ11 gene; and provided that the biological sample tests positive for the presence of a mutation in Kir6.2 protein or KCNJ11 gene, administering to the patient a therapeutically effective amount of a composition comprising tolbutamide or a physiologically equivalent salt or solvate thereof and a pharmaceutically acceptable carrier. Also provided herein are methods of maintaining and/or improving eye health in a subject, comprising: administering to the patient a therapeutically effective amount of a composition comprising tolbutamide or a physiologically equivalent salt or solvate thereof, and a pharmaceutically acceptable carrier.

Claim (Index 15):
The method of  claim 1 , wherein the glaucoma is normal tension open angle glaucoma or exfoliative glaucoma.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 93.0
- Lexical Diversity: 2.32143
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15102201', '10510585', '12134002', '11615454', '13807355']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7846731544055492
- 35 USC 102 Novelty (BERT): 0.4990372095058435
- Combined Prediction Score: 0.7561095599155787
- Mean Citation Score: 242.022224
- Max Citation Score: 270.4261
- Similarity Product: 224.0530294005513

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test